Big Movers: IXYS Corp. (NASDAQ:IXYS), ON Semiconductor Corp. (NASDAQ:ONNN), Eltek (NASDAQ:ELTK), ProPhase Labs (NASDAQ:PRPH), Pacira Pharmaceuticals (NASDAQ:PCRX)


On 31 October IXYS Corp (NASDAQ:IXYS) announced its earnings results on Friday. The company reported $0.18 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.16 by $0.02. The company had revenue of $86.40 million for the quarter, compared to the consensus estimate of $88.50 million. During the same quarter last year, the company posted $0.23 earnings per share. IXYS’s revenue was up .6% compared to the same quarter last year. IXYS Corp. (NASDAQ:IXYS) in last trading activity moved up 1.39% to close at $11.66. Company weekly performance is 1.75% while its quarterly performance stands at 0.34%. IXYS Corp. (NASDAQ:IXYS) is -21.35% away from its 52 week high.

 

ON Semiconductor Corp (NASDAQ:ONNN) EVP William Hall sold 3,824 shares of the company’s stock on the open market in a transaction dated Monday, November 3rd. The shares were sold at an average price of $8.20, for a total value of $31,356.80. Following the transaction, the executive vice president now directly owns 354,464 shares in the company, valued at approximately $2,906,605. On last trading day ON Semiconductor Corp. (NASDAQ:ONNN) remains unchanged to close at $8.25. Its volatility for the week is 2.05% while volatility for the month is 3.47%. ONNN’s sales growth for past 5 years was 6.30% and its EPS growth for past 5 years was 18.00%. ON Semiconductor Corp. (NASDAQ:ONNN) monthly performance is 10.29%.
On 23 October Eltek Ltd. (NASDAQ:ELTK) has entered into an agreement to acquire Singapore-based EV Industrial Pte. Ltd. On last trading day Eltek Ltd. (NASDAQ:ELTK) decreased -2.00% to close at $1.47. Its volatility for the week is 4.52% while volatility for the month is 4.41%. ELTK’s sales growth for past 5 years was 3.10% and its EPS growth for past 5 years was 28.00%. Eltek Ltd. (NASDAQ:ELTK) monthly performance is -3.92%.
ProPhase Labs, Inc. (NASDAQ:PRPH) major shareholder Braden Michael Leonard acquired 64,746 shares of the stock on the open market in a transaction dated Friday, November 7th. The stock was purchased at an average cost of $1.34 per share, for a total transaction of $86,759.64.ProPhase Labs, Inc. (NASDAQ:PRPH) has 41.01% insider ownership while its institutional ownership stands at 18.30%. In last trading activity company’s stock closed at $1.35.
On 30 October Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) announced consolidated financial results for the third quarter ended September 30, 2014.  EXPAREL net product sales were $50.2 million in the third quarter of 2014, compared to $20.0 million in the third quarter of 2013 and up 12 percent from $44.9 million in the second quarter of 2014. On Monday shares of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) closed at $87.83. Company’s sales growth for last 5 years was 43.80%


Leave a Reply

Your email address will not be published. Required fields are marked *